Okay, but you're not getting my question, which is this. For consumer safety, there has to be a body that is independent of drug companies. Anyone with a stakeholder interest, who actually has a role in assessing the adverse reactions of drugs or whether or not this drug should stay on the market, should be pulled. I don't see that anywhere in this scheme of things, anywhere.
We used to have an independent drug research bureau. We don't have that. We were told, oh, we're going to give this to third parties, universities. I remember that coming from the Minister of Health. I've never seen any evidence of a body being set up.
You've now presented us with this new framework and this new plan around a life cycle approach. Where is the independent analysis, pre- and post-market?